Download full report with analyst certification and important disclosures
Jan 27 2025, 08:17 GMT
hVIVO
Letter of intent expected to lead to largest ever human challenge trial
- Sectors : Pharma and healthcare
- Companies : hVIVO
DAVY VIEW
hVIVO has announced that it has signed a letter of intent (LOI) with a US biotech company to conduct a first ever human challenge trial for a whooping cough vaccine candidate. A further announcenment will be made in due course. The trial is expected to commence in H2 2025.
